ohsu

New Report Shows Oregon Clinical Trials Benefit State’s Health and Economy

The Lund Report
Clinical trials of new medicines target the most debilitating chronic diseases

Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a report released today shows.

Maternal Nutrition and Fetal Development Focus of OHSU’s New Research Center

The Lund Report
Dr. Kent Thornburg, whose research focuses on the developmental origins of disease, will take the helm of the Bob and Charlee Moore Institute for Nutrition and Wellness

February 1, 2012 -- Dr. Kent Thornburg, who teaches in the Division of Cardiovascular Medicine at Oregon Health & Science University and is known worldwide for his research into the developmental origins of disease – has been named interim director of the Bob and Charlee Moore Institute for Nutrition and Wellness, a new research and education center.

Dr. Charles Kilo Believes Competition Drives Up Healthcare Costs

The Lund Report
Calling himself a dyed in the woods capitalist, he suggests we focus on the social determinants of health rather than spending more on healthcare services

January 18, 2012 -- As policymakers wrestle with transforming Oregon’s healthcare system to control costs and improve quality, competition stands in the way, according to Dr. Charles Kilo, chief medical officer at Oregon Health & Science University.

Debt restructuring, Plans for Nutritional Center Take Center Stage at OHSU

The Lund Report
At its board meeting last Friday, a plan was approved to restructure its variable rate debt to a more stable structure

December 6, 2011 – Oregon Health & Science University intends to restructure approximately $210 million of its variable rate debt, and replace old auction rate debt with a more stable funding structure following Friday’s board meeting.

Chief Financial officer Lawrence Furnstahl had urged the board to take advantage of favorable conditions -- annual fees for credit will drop by two-thirds, from 1.80 percent to less than .60 percent for a three-year commitment, saving the university approximately $2 million a year.

Yale Chooses Oregon Evidence-Based Practice Center for Review of Bone Growth Product

The Lund Report
Center will analyze data on patients given controversial product as part of spinal surgeries

December 5, 2011 -- Yale School of Medicine has chosen the Oregon Evidence-based Practice Center at Oregon Health & Science University as one of two research centers that will independently review all clinical studies of a controversial product used in spinal surgeries to promote bone growth.

The selection of the Oregon Evidence-based Practice Center comes after Yale had entered into an unusual agreement with Medtronic, the manufacturer of the bone growth product — called bone morphogenetic protein-2 — to independently review the product.

Less Paperwork, More Patient Focus Can Dramatically Improve Care, Expert Says

The Lund Report
Inefficiency continues to plague the medical system, according to Dr. David Reuben director and professor geriatric medicine at UCLA’s David Geffen School of Medicine

November 16, 2011 -- Surveys of doctors show that now more than half think that providing higher-quality medicine may lead to losses in their earning power, a belief that may help explain why an exceptionally high number of patients don’t get recommended care, according to Dr. David Reuben MD, who spoke at the OHSU Foundation for Medical Excellence annual lecture earlier this week.

Pages

Subscribe to ohsu